id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-P-0591-0004,FDA,FDA-2008-P-0591,"Regulus Pharmaceutical Consulting, Inc. - Supplement",Other,SUP-Supplement,2010-03-17T04:00:00Z,2010,3,2010-03-17T04:00:00Z,,2013-07-27T23:11:39Z,,0,0,0900006480abbc37
FDA-2008-P-0591-0005,FDA,FDA-2008-P-0591,"Attachment A - ""Clinical Pharmacology and Biophamaceutics Executive Summary"" - [Regulus Pharmaceutical Consulting, Inc. - Supplement]",Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2010-03-17T04:00:00Z,2010,3,,,2010-03-17T21:43:49Z,,0,0,0900006480abc01d